Cangiano, Jose
Cangiano, Jose was paid $526K by Medicaid between Jan 2018 and Nov 2024, across 17 billing codes. Its largest line is Q0084, Chemotherapy administration by infusion technique only, per visit — 47% of everything it billed.
33Billing provider infoCANGIANO, JOSE
PONCE, PR 00730
PONCE, PR 00730
33aNPI1114961091assigned 06/15/2006
33bProvider typeSpecialist
28Total paid$526K
24GClaims12,677
24DCodes billed17
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Specialist providers in Puerto Rico
Rank by total paid#42 of 316
Median peer was paid$26K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,072 | $105K | |
| 2019 | 2,560 | $91K | |
| 2020 | 2,366 | $97K | |
| 2021 | 1,978 | $79K | |
| 2022 | 890 | $35K | |
| 2023 | 1,306 | $85K | |
| 2024incomplete | 505 | $34K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| Q0084 | Chemotherapy administration by infusion technique only, per visit | 47% | 3,161 | 1,603 | $247K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 2,184 | 1,913 | $73K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 13% | 1,118 | 580 | $69K |
| 96415 | 5.7% | 739 | 384 | $30K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 5.2% | 813 | 442 | $27K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4.4% | 614 | 499 | $23K |
| 99443 | 4.3% | 375 | 275 | $23K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.6% | 1,039 | 518 | $14K |
| Q0081 | Infusion therapy, using other than chemotherapeutic drugs, per visit | 2.0% | 126 | 100 | $10K |
| 99070 | 1.0% | 596 | 381 | $5K | |
| 96367 | <1% | 66 | 36 | $2K | |
| J3489 | Injection, zoledronic acid, 1 mg | <1% | 40 | 37 | $1K |
5 more codes
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 356 | $494.81 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 423 | $243.98 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 359 | $109.39 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 651 | $106.65 |
| J2323 | Injection, natalizumab, 1 mg | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.